Developing DNA Vaccines Against Immunodeficiency Viruses
More than a decade after the identification of human immunodeficiency virus-1 (HIV-1) as the causative pathogen of AIDS, the prospects for an HIV-1 vaccine in the foreseeable future are still low. Attempts using conventional vaccine approaches have not met with much success (for recent reviews see Haynes 1993; Bolognesi 1993, 1995). The live attenuated vaccine approach appeared promising when its effectiveness was demonstrated in a simian immunodeficiency virus (SIV) model in macaques (Daniel et al. 1994, 1992). However, additional studies in neonatal macaques raised safety concerns regarding this approach (Baba et al. 1995). The search for novel vaccine strategies that target the unique biological features of HIV-1 remains a challenging yet important task.
KeywordsHuman Immunodeficiency Virus Type Simian Immunodeficiency Virus Simian Immunodeficiency Virus Infection Human Immunodeficiency Virus Vaccine Control Macaque
Unable to display preview. Download preview PDF.
- Bolognesi DP (1995) Ch. 20: The dilemma of developing and testing AIDS vaccines. In: Copper GM, Temin RG, and Sugden B (eds) The DNA provirus: Howard Temin’s scientific legacy. American Society for Microbiology, Washington, DC, pp 301–312Google Scholar
- Dresser DW (1986) Immunization of experimental animals. In Weir DM (ed.): Immunochemistry, Handbook of Experimental Immunology, Blackwell Scientific Publications, Oxford, 1:8.1–8.21.Google Scholar
- Giard M, Kieny M-P, Pinter A, Barre-Sinoussi F, Nara P, Kolbe H, Kusumi K, Chaput A, Reinhart T, Muchmore E, Ronco J, Kaczorek M, Gomard E, Gluckman J-C, Fultz PN (1991) Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88:542–546CrossRefGoogle Scholar
- Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, Corey L, Bolognesi DP, Sin DM, Esterlitz JR, Hu S-L, Smith GE and NIAID AIDS vaccine clinical trials network. (1994) Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. J Infect Dis 170:782–786PubMedCrossRefGoogle Scholar
- Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Robinson HL (1996) DNA vaccines against rotavirus infections. Arch Virol (in press)Google Scholar
- Li J, Haseltine W, Letvin NL, Sodroski J (1992) Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that express the HIV-1 envelope glycoprotein. J AIDS 5:639–664Google Scholar
- Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM, and the National Institutes of Health AIDS Vaccine Clinical Trials Network (1994) Binding of human immunodeficiency virus 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. J Infect Dis 170:429–32PubMedCrossRefGoogle Scholar
- Robinson HL, Feltquate DM, Morin MJ, Haynes JR, Webster RG (1995) DNA vaccines: a new approach to immunization. In: Chanock RM, Brown F, Ginsberg HS and Norrby E (eds) Vaccines 95. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 69–75Google Scholar
- Shafferman A, Jahrling PB, Benveniste RE, Lewis MG, Phipps TJ, Eden-McCutchan F, Sadoff J, Eddy GA, Burke DS (1991) Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci USA 88:7126–7130PubMedCrossRefGoogle Scholar
- Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgonery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749PubMedCrossRefGoogle Scholar
- Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadmanyan MG, Gilbert L, Ugen KE, Williams WV, Weiner DB (1993b) DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA and Cell Biology 12:799–805PubMedCrossRefGoogle Scholar